TMCI Treace Medical Concepts, Inc.
Treace Medical Concepts, Inc. (TMCI) is expected to report earnings on February 5, 2027, before the market open. The consensus earnings estimate is a loss of $0.08 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of +11.9% since its last earnings release on November 6, 2026.
Sign in or subscribe to unlock sentiment, short interest, and technical indicators.
Whisperings™
About Treace Medical Concepts, Inc.
Treace Medical Concepts is a commercial-stage orthopaedic medical device company with the goal of advancing the standard of care for the surgical management of bunion deformities.
Sector
Healthcare
Industry
Medical Appliances/Equipment
Held By 2 ETFs, by dollar flow
Charts powered in part by Lightweight Charts™ by TradingView.